Prospective evaluation of the factors predicting the prognosis of advanced hepatocellular carcinoma (HCC) patients treated with sorafenib.

被引：1
作者：
Adachi, Takuya
Nouso, Kazuhiro
Miyahara, Koji
Dohi, Chihiro
Wada, Nozomu
Takeuchi, Yasuto
Kuwaki, Kenji
Onishi, Hideki
Ikeda, Fusao
Nakamura, Shinichiro
Shiraha, Hidenori
Takaguchi, Koichi
Uematsu, Shuji
Iwadou, Shouta
Takuma, Yoshitaka
Hagihara, Hiroaki
Takabatake, Hiroyuki
Takaki, Akinobu
Okada, Hiroyuki
机构：
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan
[2] Okayama Univ, Dept Gastroenterol & Hepatol, Okayama, Japan
[3] Hiroshima City Hiroshima Citizens Hosp, Hiroshima, Japan
[4] Kagawa Prefectural Cent Hosp, Takamatsu, Kagawa, Japan
[5] Sumitomo Besshi Hosp, Nihama City, Japan
[6] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15674
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15674
引用
收藏
页数：6
相关论文
共 50 条
  • [31] A phase II study of TR105 in patients with hepatocellular carcinoma (HCC) who have progressed on sorafenib.
    Duffy, Austin G.
    Rahma, Osama E.
    Ulahannan, Susanna Varkey
    Fioravanti, Suzanne
    Venkatesan, Aradhana
    Turkbey, Ismail B.
    Choyke, Peter L.
    Trepel, Jane B.
    Figg, William Douglas
    Greten, Tim F.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] A phase I study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Yopp, Adam
    Arriega, Yuii
    Singal, Amit
    Mansour, John
    Bach, Glen
    Thorpe, Phillip
    CANCER RESEARCH, 2012, 72
  • [33] Relationship between ethnicity and overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S).
    Meyers, Daniel E.
    Lee-Ying, Richard M.
    Alghamdi, Mohammed Abdullah
    Cheung, Winson Y.
    Samawi, Haider
    Tam, Vincent C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [34] An international cohort study investigating the impact of age on clinical outcome in patients with hepatocellular carcinoma treated with sorafenib.
    Sharma, Rohini
    Hajiev, Saur
    Aval, Leila Motedayan
    Bettinger, Dominik
    Arizumi, Tadaaki
    Pirisi, Mario
    Rimassa, Lorenza
    Personeni, Nicola
    Pressiani, Tiziana
    Giordano, Laura
    Kudo, Masatoshi
    Thimme, Robert
    Park, Joong-Won
    Taddei, Tamar Hamosh
    Kaplan, David Edward
    Ramaswami, Ramya
    Pinato, David James
    Allara, Elias
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Sorafenib in advanced hepatocellular carcinoma (HCC) : Ascites as prognostic factor
    Koch, S.
    Niederle, I.
    Gamstaetter, T.
    Schuchmann, M.
    Galle, P.
    Woerns, M.
    Weinmann, A.
    INTERNIST, 2013, 54 (06): : 745 - 745
  • [36] Analyses of progressive disease patients with advanced hepatocellular carcinoma treated with sorafenib: prognosis, treatment, and progression pattern
    Yamane, Keiko
    Nakazawa, Takahide
    Koizumi, Wasaburo
    HEPATOLOGY, 2015, 62 : 452A - 452A
  • [37] Changes in the neutrophil-to-lymphocyte ratio predict the prognosis of patients with advanced hepatocellular carcinoma treated with sorafenib
    Hong, Young Mi
    Yoon, Ki Tae
    Hwang, Tae Ho
    Heo, Jeong
    Woo, Hyun Young
    Cho, Mong
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (10) : 1250 - 1255
  • [38] SORAFENIB IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC): A PROSPECTIVE OBSERVATIONAL STUDY ON SIDE EFFECTS AND QUALITY OF LIFE
    Brunocilla, Paola Rita
    Gaia, Silvia
    Carucci, Patrizia
    Rolle, Emanuela
    Castiglione, Anna
    Rizzetto, Mario
    Brunello, Franco
    HEPATOLOGY, 2011, 54 : 1396A - 1396A
  • [39] Sorafenib in advanced hepatocellular carcinoma (HCC) : Ascites as prognostic factor
    Koch, S.
    Niederle, I.
    Gamstaetter, T.
    Schuchmann, M.
    Galle, P.
    Woerns, M.
    Weinmann, A.
    INTERNIST, 2013, 54 : 10 - 10
  • [40] A single center experience of sorafenib in advanced hepatocellular carcinoma patients: evaluation of prognostic factors
    Song, Tianqiang
    Zhang, Wei
    Wu, Qiang
    Kong, Dalu
    Ma, Weiwei
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (12) : 1233 - 1238
12345